Lunai Bioworks Inc. Common Stock (LNAI) is a publicly traded the market company. As of May 20, 2026, LNAI trades at $0.24 with a market cap of $9.38M and a P/E ratio of 0.00. LNAI moved -2.32% today. Year to date, LNAI is -74.25%; over the trailing twelve months it is flat. Its 52-week range spans $0.15 to $1.66. Rallies surfaces LNAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Lunai Bioworks Approves 1-for-8 Reverse Split to Restore $1 Nasdaq Minimum: Lunai Bioworks will effect a 1-for-8 reverse stock split at 12:01 a.m. ET on May 22, 2026 to regain compliance with Nasdaq’s $1.00 minimum bid rule. The consolidation will reduce issued and outstanding shares from about 36.27 million to roughly 4.53 million and adjust all existing equity awards proportionally.
| Metric | Value |
|---|---|
| Price | $0.24 |
| Market Cap | $9.38M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.66 |
| 52-Week Low | $0.15 |
| Volume | 970.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
LNAI analyst coverage data. Average price target: $0.00.